{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:59:15Z","timestamp":1783015155871,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":1291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jpainsymman.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T09:55:45Z","timestamp":1464429345000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Furosemide"],"prefix":"10.1016","volume":"52","author":[{"given":"Laura","family":"Carone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Oxberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Twycross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Charlesworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Mihalyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wilcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2016.05.004_bib1","unstructured":"NICE (2010) Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. Clinical Guideline. CG108. 2010. Available from: www.nice.org.uk. Accessed March\u00a02016."},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib3","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s11255-014-0724-z","article-title":"Combination therapy with low-dose metolazone and furosemide: a \u201cneedleless\u201d approach in managing refractory fluid overload in elderly renal failure patients under palliative care","volume":"46","author":"Cheng","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2165\/00003495-198428050-00003","article-title":"Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use","volume":"28","author":"Ward","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"Comprehensive heart failure practice guideline","volume":"16","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2125.2007.03035.x","article-title":"Sublingual administration of furosemide: new application of an old drug","volume":"64","author":"Haegeli","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib10","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jhm.991","article-title":"Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials","volume":"7","author":"Amer","year":"2012","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1345\/aph.1E172","article-title":"Subcutaneous furosemide","volume":"38","author":"Goenaga","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1049909112465795","article-title":"Intermittent subcutaneous furosemide: parentral diuretic rescue for hospice patients with congestive heart failure resistant to oral diuretic","volume":"30","author":"Farless","year":"2012","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/0269216311399490","article-title":"Is there a role for subcutaneous furosemide in the community and hospice management of end-stage heart failure?","volume":"25","author":"Zacharias","year":"2011","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmjspcare-2012-000296","article-title":"Subcutaneous furosemide as palliative treatment in patients with advanced and terminal-phase heart failure","volume":"3","author":"Galindo-Ocana","year":"2013","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.5694\/j.1326-5377.2010.tb04050.x","article-title":"Nebulised frusemide for the symptomatic treatment of end-stage congestive heart failure","volume":"193","author":"Towers","year":"2010","journal-title":"Med J Aust"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.288.6423.1041","article-title":"Intravenous infusion of frusemide as treatment for ascites in malignant disease","volume":"288","author":"Amiel","year":"1984","journal-title":"BMJ"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004836-198100031-00016","article-title":"Diuresis in the ascitic patient: a randomized controlled trial of three regimens","volume":"3","author":"Fogel","year":"1981","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.mcg.0000210101.74618.61","article-title":"The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites","volume":"40","author":"Kalambokis","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib20","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/ndt\/gfh871","article-title":"Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites","volume":"20","author":"Kalambokis","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jpainsymman.2007.10.017","article-title":"Nebulized furosemide for the management of dyspnea: does the evidence support its use?","volume":"36","author":"Newton","year":"2008","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0885-3924(02)00479-7","article-title":"Re: nebulized furosemide for dyspnea in terminal cancer patients","volume":"24","author":"Stone","year":"2002","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1164\/ajrccm\/142.1.143","article-title":"Inhaled furosemide inhibits cough induced by low-chloride solutions but not by capsaicin","volume":"142","author":"Ventresca","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJM198910193211602","article-title":"Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions","volume":"321","author":"Bianco","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib25","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1164\/ajrccm.161.6.9910009","article-title":"Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea","volume":"161","author":"Nishino","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.pupt.2007.02.003","article-title":"Inhaled furosemide does not alleviate respiratory effort during flow-limited exercise in healthy subjects","volume":"21","author":"Laveneziana","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib27","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.hlc.2012.03.002","article-title":"The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure","volume":"21","author":"Newton","year":"2012","journal-title":"Heart Lung Circulation"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resp.2006.07.004","article-title":"Effect of inhaled furosemide on air hunger induced in healthy humans","volume":"156","author":"Moosavi","year":"2006","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib29","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1164\/rccm.200308-1171OC","article-title":"Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease","volume":"169","author":"Ong","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/thx.2007.085993","article-title":"Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD","volume":"63","author":"Jensen","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib31","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.4187\/respcare.02160","article-title":"The adjunctive effect of nebulized furosemide in acute treatment of patients with chronic obstructive pulmonary disease exacerbation: a randomized controlled clinical trial","volume":"58","author":"Sheikh Motahar Vahedi","year":"2013","journal-title":"Respir Care"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0885-3924(01)00367-0","article-title":"Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients","volume":"23","author":"Shimoyama","year":"2002","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0885-3924(03)00322-1","article-title":"Effect of nebulized furosemide in terminally ill cancer patients with dyspnea","volume":"26","author":"Kohara","year":"2003","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib34","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/thx.2007.091538","article-title":"Randomised, placebo-controlled trial of nebulised furosemide for breathlessness in patients with cancer","volume":"63","author":"Wilcock","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/j.1875-9114.1997.tb03681.x","article-title":"Variable furosemide absorption and poor predictability of response in elderly patients","volume":"17","author":"Murray","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1345\/aph.1D332","article-title":"Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study","volume":"38","author":"Verma","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/bmj.315.7106.464","article-title":"Withdrawal of long term diuretic medication in elderly patients: a double blind randomised trial","volume":"315","author":"Walma","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib38","unstructured":"Baxter K, Preston CL. Stockley's drug onteractions. London: Pharmaceutical Press. Available from: www.medicinescomplete.com. Accessed March\u00a02016."},{"key":"10.1016\/j.jpainsymman.2016.05.004_bib39","series-title":"Handbook on injectable drugs","author":"Trissel","year":"2013"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392416301191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392416301191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:17:08Z","timestamp":1760131028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392416301191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0885392416301191"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.05.004","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Furosemide","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 U.S. Cancer Pain Relief Committee. The scientific content of the article also appears on the website www.palliativedrugs.com, and is used with permission. The scientific content of the article also appears on the website www.palliativedrugs.com, and is used with permission","name":"copyright","label":"Copyright"}]}}